METHODS FOR VIRAL ONCOAPOPTOSIS IN CANCER THERAPY

Details for Australian Patent Application No. 2002303294 (hide)

Owner MOUNT SINAI SCHOOL OF MEDICINE OF NEW YORK UNIVERSITY

Inventors BLAHO, John, A.; AUBERT, Martine

Pub. Number AU-A-2002303294

PCT Number PCT/US02/11228

PCT Pub. Number WO2002/088327

Priority 60/282,214 06.04.01 US

Filing date 8 April 2002

Wipo publication date 11 November 2002

International Classifications

C12N 001/21 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 015/11 Mutation or genetic engineering - DNA or RNA fragments

C12N 015/85 Mutation or genetic engineering - for animal cells

C12N 015/86 Mutation or genetic engineering - Viral vectors

C07K 005/00 Peptides having up to four amino acids in a fully defined sequence

A61K 048/00 Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

Event Publications

12 December 2002 Complete Application Filed

  Priority application(s): 60/282,214 06.04.01 US

17 April 2003 Application Open to Public Inspection

  Published as AU-A-2002303294

19 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002303295-Diagnosis and treatment of neural disease and injury using microvoltammetry

2002303293-TRIAZA COMPOUND IMMUNOREGULATORY AGENTS